(Q41205600)

English

Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol: Two-Year Results

scientific article published on 15 October 2015

Statements

Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol: Two-Year Results (English)
Lars Haakon Berger
Kristian Fossen
Slavica Markovic
Terje R Pedersen
Ragnheiður Bragadóttir

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit